This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by O’Donovan, N. Articles by Duffy, M. J. Search for Related Content PubMed PubMed Citation Articles by O’Donovan, N. Articles by Duffy, M. J.

Caspase 3 in Breast Cancer

Departments of Medical Oncology [N. O’D., J. C.] and Nuclear Medicine [M. J. D.], St. Vincent’s University Hospital, and Department of Surgery [H. S., A. D. K. H., E. M., N. O’H., M. J. D.] and Conway Institute of Biomolecular and Biomedical Science [A. D. K. H., M. J. D.], University College Dublin, Dublin 4, Ireland

Purpose: An inability to undergo apoptosis is widely thought to contribute to both tumorigenesis and tumor progression. One of the key mediators of apoptosis is the thiol protease caspase 3. In this investigation, caspase 3 mRNA and protein expression in breast cancer was examined.

Experimental Design: Caspase 3 was measured at the mRNA level using reverse transcription-PCR and at the protein level using both Western blotting and activity assays. Levels of apoptosis were determined using an ELISA, which detects nucleosomes released during DNA fragmentation.

Results: Relative levels of caspase 3 mRNA were similar in breast carcinomas (n = 103), fibroadenomas (n = 25), and normal breast tissues (n = 6). However, levels of both the precursor and active forms of caspase 3 were significantly higher in carcinomas compared with both fibroadenomas (P = 0.0188) and normal breast tissues (P = 0.0002). Levels of apoptosis were also highest in the carcinomas and correlated significantly with active caspase 3 levels (r = 0.481; P = 0.0003). In the carcinomas, expression of caspase 3 showed no significant relationship with either tumor size, tumor grade, nodal status, or steroid receptor status but was significantly higher in ductal carcinomas than in lobular carcinomas (P = 0.0188).

Conclusions: We conclude that rates of apoptosis as measured by both caspase 3 activation and nucleosome release are higher in breast cancer than in nonmalignant breast tissue. This finding would appear to conflict with the widely held belief that apoptosis is reduced in malignancy. The proliferation:apoptosis ratio, however, may be higher in carcinomas than in the corresponding normal tissue.

This article has been cited by other articles:

				S. A. Martin and T. Ouchi BRCA1 Phosphorylation Regulates Caspase-3 Activation in UV-Induced Apoptosis Cancer Res., December 1, 2005; 65(23): 10657 - 10662. [Abstract] [Full Text] [PDF]

				M. Sunde, K. C. Y. McGrath, L. Young, J. M. Matthews, E. L. Chua, J. P. Mackay, and A. K. Death TC-1 Is a Novel Tumorigenic and Natively Disordered Protein Associated with Thyroid Cancer Cancer Res., April 15, 2004; 64(8): 2766 - 2773. [Abstract] [Full Text] [PDF]

				P. Luciani, P. Ferruzzi, G. Arnaldi, C. Crescioli, S. Benvenuti, G. Nesi, A. Valeri, I. Greeve, M. Serio, M. Mannelli, et al. Expression of the Novel Adrenocorticotropin-Responsive Gene Selective Alzheimer's Disease Indicator-1 in the Normal Adrenal Cortex and in Adrenocortical Adenomas and Carcinomas J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1332 - 1339. [Abstract] [Full Text] [PDF]